Atlas Trials

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Clinical trial NCT02483000 · TERMINATED

Trial details

NCT number
NCT02483000
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Burkitt LymphomaCD20-Positive Neoplastic Cells PresentDiffuse Large B-Cell LymphomaIndolent Non-Hodgkin LymphomaMantle Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRefractory Mature B-Cell Non-Hodgkin Lymphoma
Start date
2017-02-01
Primary completion
2019-11-17
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.